Latest First Turn Management, LLC Stock Portfolio

First Turn Management, LLC Performance:

2024 Q3: 6.67%YTD: 15.28%

Performance for 2024 Q3 is 6.67%, and YTD is 15.28%.

About First Turn Management, LLC and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, First Turn Management, LLC reported an equity portfolio of $631.6 Millions as of 30 Sep, 2024.

The top stock holdings of First Turn Management, LLC are NUVL, , INSM. The fund has invested 5.8% of it's portfolio in NUVALENT INC and 4.7% of portfolio in ARGENX SE.

The fund managers got completely rid off SAREPTA THERAPEUTICS INC (SRPT), IMMUNOVANT INC (IMVT) and DEXCOM INC (DXCM) stocks. They significantly reduced their stock positions in KALVISTA PHARMACEUTICALS INC (KALV), KRYSTAL BIOTECH INC (KRYS) and ARGENX SE. First Turn Management, LLC opened new stock positions in NATERA INC (NTRA), ARCELLX INC (ACLX) and VERONA PHARMA PLC (VRNA). The fund showed a lot of confidence in some stocks as they added substantially to SYNDAX PHARMACEUTICALS INC (SNDX), VERA THERAPEUTICS INC (VERA) and NUVALENT INC (NUVL).

First Turn Management, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that First Turn Management, LLC made a return of 6.67% in the last quarter. In trailing 12 months, it's portfolio return was 50.31%.

New Buys

Ticker	$ Bought
natera inc	19,759,800
arcellx inc	17,896,000
verona pharma plc	16,483,100
harrow inc	14,683,100
bicara therapeutics inc	14,324,100
geron corp	14,187,400
adma biologics inc	13,293,000
day one biopharmaceuticals i	13,203,900

New stocks bought by First Turn Management, LLC

Additions

Ticker	% Inc.
syndax pharmaceuticals inc	85.38
vera therapeutics inc	53.32
nuvalent inc	42.35
enliven therapeutics inc	29.49
rocket pharmaceuticals inc	10.75
insmed inc	10.23

Additions to existing portfolio by First Turn Management, LLC

Reductions

Ticker	% Reduced
kalvista pharmaceuticals inc	-66.49
krystal biotech inc	-37.79
argenx se	-31.93
vertex pharmaceuticals inc	-30.52
intuitive surgical inc	-27.8
intra-cellular therapies inc	-26.64
axsome therapeutics inc	-24.3
cytokinetics inc	-23.92

First Turn Management, LLC reduced stake in above stock

Sold off

Ticker	$ Sold
alphatec hldgs inc	-14,216,300
immunovant inc	-18,359,300
silence therapeutics plc	-10,209,400
spyre therapeutics inc	-10,918,900
ideaya biosciences inc	-13,966,100
revolution medicines inc	-12,788,600
apogee therapeutics inc	-12,526,200
immunocore hldgs plc	-9,864,900

First Turn Management, LLC got rid off the above stocks

Sector Distribution

First Turn Management, LLC has about 83.5% of it's holdings in Healthcare sector.

Sector	%
Healthcare	83.5
Others	15.2
	1.4

Market Cap. Distribution

First Turn Management, LLC has about 12.2% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
MID-CAP	50.6
SMALL-CAP	22
UNALLOCATED	15.2
LARGE-CAP	12.2

Stocks belong to which Index?

About 68.7% of the stocks held by First Turn Management, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index	%
RUSSELL 2000	63.8
Others	31.3
S&P 500	4.9

Top 5 Winners (%)		%
ORIC	oric pharmaceuticals inc	44.9 %
PCVX	vaxcyte inc	43.3 %
NUVL	nuvalent inc	31.9 %
ACLX	arcellx inc	27.8 %
SBTX	ars pharmaceuticals inc	27.3 %

Top 5 Winners ($)		$
NUVL	nuvalent inc	8.9 M
PCVX	vaxcyte inc	8.5 M
ORIC	oric pharmaceuticals inc	4.8 M
ACLX	arcellx inc	3.9 M
MIRM	mirum pharmaceuticals inc	3.4 M

Top 5 Losers (%)		%
MRUS	merus n v	-15.4 %
BPMC	blueprint medicines corp	-14.1 %
RCKT	rocket pharmaceuticals inc	-13.5 %
SNDX	syndax pharmaceuticals inc	-6.2 %
RLAY	relay therapeutics inc	-5.1 %

Top 5 Losers ($)		$
MRUS	merus n v	-2.9 M
BPMC	blueprint medicines corp	-2.8 M
RCKT	rocket pharmaceuticals inc	-1.8 M
SNDX	syndax pharmaceuticals inc	-1.5 M
ESTA	establishment labs hldgs inc	-0.8 M

First Turn Management, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of First Turn Management, LLC

First Turn Management, LLC has 38 stocks in it's portfolio. About 39.3% of the portfolio is in top 10 stocks. MRUS proved to be the most loss making stock for the portfolio. NUVL was the most profitable stock for First Turn Management, LLC last quarter.

Last Reported on: 07 Nov, 2024

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
ACLX	arcellx inc	2.83	214,298	17,896,000	new

ADMA	adma biologics inc	2.10	664,985	13,293,000	new

AGLE	spyre therapeutics inc	0.00	0.00	0.00	sold off	-100

ATEC	alphatec hldgs inc	0.00	0.00	0.00	sold off	-100

AXSM	axsome therapeutics inc	3.63	255,294	22,943,300	reduced	-24.3

BBIO	bridgebio pharma inc	1.61	399,781	10,178,400	new

BPMC	blueprint medicines corp	2.62	178,929	16,550,900	reduced	-3.23

CRNX	crinetics pharmaceuticals in	2.86	353,376	18,057,500	reduced	-4.31

CYTK	cytokinetics inc	1.86	223,147	11,782,200	reduced	-23.92

DAWN	day one biopharmaceuticals i	2.09	947,878	13,203,900	new

DXCM	dexcom inc	0.00	0.00	0.00	sold off	-100

ESTA	establishment labs hldgs inc	2.45	357,003	15,447,500	reduced	-3.51

GERN	geron corp	2.25	3,124,970	14,187,400	new

GKOS	glaukos corp	1.98	96,097	12,519,500	new

HROW	harrow inc	2.33	326,582	14,683,100	new

IDYA	ideaya biosciences inc	0.00	0.00	0.00	sold off	-100

IMCR	immunocore hldgs plc	0.00	0.00	0.00	sold off	-100

IMVT	immunovant inc	0.00	0.00	0.00	sold off	-100

INSM	insmed inc	4.12	356,451	26,020,900	added	10.23

ISRG	intuitive surgical inc	2.35	30,254	14,862,900	reduced	-27.8